Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-03-18 | The following table sets forth the name, age and positions of each Director Nominee: Linda Tharby 53 Director Nominee, Chief Executive Officer (since April 2021). The Compensation Committee currently consists of Messrs. Beck (chair), Manko and Ms. Frommer. No director compensation listed for Linda Tharby. |
| 2023-03-29 | Linda Tharby President and CEO, KORU Medical Age 54 Ms. Tharby does not receive compensation for her service as a director. |
| 2024-03-28 | Ms. Tharby does not receive compensation for her service as a director. |
| 2025-04-04 | Ms. Tharby was appointed as President and CEO in April 2021. Ms. Tharby has over 25 years of executive leadership experience building and leading strong performing global organizations that develop and commercialize products and service innovations, while delivering solutions to patients in the home setting. Prior to joining KORU, Ms. Tharby spent the last 24 years working in various roles of increased responsibility at Becton Dickinson (“BD”). Ms. Tharby was a member of the Executive Leadership team of BD. From 1998 to 2016, she held numerous senior global business leadership roles at BD, including Executive Vice President and President of Life Sciences, Group President of Pre-Analytical Systems and Biosciences, Worldwide President of Diabetes Care, and Vice President/General Manager of Pharmaceutical Systems. Ms. Tharby’s last role was as Chief Customer Experience Officer from July 2018 through December 2020. Prior to that she served as BD’s Chief Human Resources Officer, from October 2016 through July 2018. Ms. Tharby has an Honors Bachelor of Business Administration from Wilfrid Laurier University in Waterloo, Ontario Canada. |
Data sourced from SEC filings. Last updated: 2025-08-30